Cleared Traditional

K123803 - REVERSE MEDICAL MICRO VASCULAR PLUG (MVP) SYSTEM

K123803 is an FDA 510(k) clearance for REVERSE MEDICAL MICRO VASCULAR PLUG (MV..., manufactured by Reverse Medical Corporation. The device is a Class 2 Cardiovascular device with product code KRD cleared through the Traditional 510(k) pathway after a 204-day FDA review.

K123803 · Reverse Medical Corporation · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
204d
Days
Class 2
Risk

K123803 is an FDA 510(k) clearance for the REVERSE MEDICAL MICRO VASCULAR PLUG (MVP) SYSTEM. Classified as Device, Vascular, For Promoting Embolization (product code KRD), Class II - Special Controls.

Submitted by Reverse Medical Corporation (Irvine, US). The FDA issued a Cleared decision on July 2, 2013 after a review of 204 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K123803

510(k) Number K123803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 10, 2012
Decision Date July 02, 2013
Days to Decision 204 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
79d slower than avg
Panel avg: 125d · This submission: 204d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KRD Device Classification - Class 2, Special Controls

Product Code KRD Device, Vascular, For Promoting Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRD Device, Vascular, For Promoting Embolization

All 129
Devices cleared under the same product code (KRD) and FDA review panel - the closest regulatory comparables to K123803.
MEDUSA VASCULAR PLUG
K123696 · Endoshape, Inc. · Oct 2013
EMBOZENE MICROSPHERES
K132675 · Celonova Biosciences, Inc. · Oct 2013
INTERLOCK - 18 FIBERED IDC OCCLUSION SYSTEM
K132578 · Boston Scientific Corp · Sep 2013
AZUR PUSHABLE 18 & 35 SYSTEM
K130577 · MicroVention, Inc. · Jun 2013
ONCOZENE MICROSPHERES 40UM, 2ML, ONCOZENE MICROSPHERES 75UM, 2ML, ONCOZENE MICROSPHERES 100UM, 2ML, ONCOZENE MICROSPHERE
K130307 · Celonova Biosciences, Inc. · Mar 2013
RETRACTA DETACHABLE EMBOLIZATION COIL
K123712 · Cook Incorporated · Jan 2013